Sales in the global Urology Imaging Systems Market are slated to top USD 391.6 Million in 2022. Expanding at a healthy 3.7% CAGR, the market size is projected to total USD 486.4 Million by 2028.
| Attribute | Details |
|---|---|
| Urology Imaging Systems Market Estimated Size 2022 | USD 391.6 Million |
| Urology Imaging Systems Market Value-based CAGR (2022 to 2028) | ~3.7% |
| Urology Imaging Systems Market Size in Projected 2028 | USD 486.4 Million |
The rising prevalence of various urologic diseases, such as prostate problems, bladder control problems, kidney stones, and Urinary Tract Infections (UTI) is projected to boost the sales in this market. Coupled with this, the increasing cases of multiple sclerosis and Parkinson's disease amongst the geriatric population is set to drive the market in the upcoming years.
The ongoing development of handheld urology MRI scanners by various renowned manufacturers across the globe is estimated to spur the market. The market also will gain from the growing number of international resellers of refurbished and brand new urology imaging systems.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 3.78% |
| H1, 2022 Projected | 3.68% |
| H1, 2022 Outlook | 3.48% |
| BPS Change - H1, 2022 (O) – H1, 2022 (P) | (+) 04 ↑ |
| BPS Change – H1, 2022 (O) – H1, 2021 | (-) 30 ↓ |
As per the Future Market Insights’ analysis, the H1-2022 outlook period in comparison to H1-2022 projected period showed a surge in growth rate in terms of Basis Point Share by 04 BPS.
The surge in the BPS values observed can be associated with the development of 3d printing for novel equipment, as well as translation of medical imaging into tangible replicas of patient-specific anatomy. With growing enhancements in medical imaging systems, the market is set to experience a positive growth outlook.
However, In H1-2022 when compared to H1-2021, the market growth rate of urology imaging systems is expected to fall by 30 basis point share (BPS), as per FMI analysis. The resultant drop in the BPS values in are associated with the high costs associated with the MRI compatible urology imaging systems, as well as long procedural time, thus resulting in a fall in the adoption rate.
The market is subject to changes as per the macro and industry dynamics which include disease prevalence and epidemiology, device regulations, technology adoption, and product licensing and distribution.
Key developments in the market include the collaboration of 3D printing and additive manufacturing for imaging.
The urology imaging systems market is expected to register 3.7% CAGR between 2022 and 2028, up from 3.8% CAGR recorded during 2013 to 2021, predicts Future Market Insights.
The increasing cases of kidney stones in various parts of the globe is one of the major factors bolstering the sales of urology imaging solutions. According to the National Kidney Foundation, from 2013 to 2014, the prevalence of kidney stones was 10% in the USA ., while in the late 2000s, it was 8.8%. It is likely to surge worldwide in the near future because of obesity, not drinking enough water, and consumption of sugar and protein-rich food and beverages.
Focus of various governments towards the expansion of their healthcare infrastructure also will fuel the demand for urology scanners. The market is slated to gain from the growing number of innovative diagnostic centers and the high prevalence of chronic diseases.
The increasing geriatric population is often linked to the surging prevalence of bladder outlet obstruction, urological cancer, and urinary incontinence. As per a report published by the World Health Organization (WHO) in 2017, the prevalence of urinary incontinence reported in population-based studies ranges from 9.9% to 36.1%. The rate is twice as high in older women as in older men. This trend is likely to continue in the near future, thereby propelling the growth in this market.
Principal Consultant
The surging adoption of cutting-edge urology imaging solutions by non-radiologists is projected to push the growth in this market. Innovations in PC-based designs, miniaturization of ultrasound urology imaging systems, development of the narrow band imaging cystoscopy technology, and the easy access to instant clinical information are estimated to fuel the market in the forthcoming years.
Stone formation and infections in the tract are the two common urological diseases that are expected to increase in the future backed by the high consumption of red meat and alcohol, drinking inadequate amount of water, and lack of knowledge about urological hygiene post sexual intercourse.
The WHO mentioned that an estimated 50% of women report having had an UTI at some point in their lives and more than 1 million hospitalizations take place every year because of this condition worldwide. Thus, governments around the world are taking initiatives to conduct awareness programs to educate the general public about UTI and its treatment options, which is set to bolster the demand for urology imaging solutions.
Rapid Adoption of Portable Urology Scanners to Drive the Market
The rising adoption of portable urology scanners among non-radiology specialists in the USA. is anticipated to drive the urology imaging systems market in North America. Also, the presence of various reputed healthcare device manufacturers, such as GE, Stryker Corporation, Boston Scientific Corporation, and Intuitive Surgical in the USA. is projected to accelerate adoption of urology imaging systems.
In December 2021, for instance, Proton International, a leading provider of proton therapy to cancer patients based in Florida, signed a new contract with Belgium-based medical technology company, Ion Beam Applications S.A. As per this contract, Ion will install the former’s Proteus ONE proton therapy solution in its three-story Radiation Oncology Center.
The system will be equipped with a fully integrated Quality Assurance (QA) hardware and software package, Pencil Beam Scanning (PBS), hand pendant for easy patient positioning, and Cone Beam Computed Tomography (CBCT). Thus, the engagement of leading USA.-based players in signing contracts with healthcare institutions of other countries is anticipated to spur the demand for urology scanners.
Growing Incidence of Prostate Cancer to Boost Adoption of Narrow Band Imaging Cystoscopy
The rapid expansion of the medical devices industry in Japan is likely to bolster the urology imaging systems market in East Asia during the evaluation period. The country has the highest number of the elderly population in this region. According to the World Bank data, in 2020, about 28.39% percent of Japan's population were aged 65 years and above. This number is projected to surge in the forthcoming years, thereby propelling the need for urology MRI scans.
Furthermore, the higher incidence rate of colorectal cancer and prostate cancer among the aging population is set to spur the market in Japan. The American Association for Cancer Research states that the incidence of prostate cancer surged to 58.7 in 2014 from 7.1 per 100,000 in 1975 in Japan. Driven by the abovementioned factors, the adoption of narrow band imaging cystoscopy technology is likely to grow in this country.
Increasing Obese Population to Fuel the Demand for Urology MRI Scanners
The increasing demand for cloud-based solutions with higher magnified visualization and portable urology MRI scanners equipped with novel software solutions in the UK. is set to push the growth in Europe by 2028. Besides this, the presence of a well-established healthcare system in the UK. is estimated to propel the market in the near future.
The increasing cases of obesity owing to the surging consumption of junk food and adoption of unhealthy lifestyles is anticipated to spur the market in the UK. According to Cancer Research UK., 1 in 6 men will get prostate cancer at some point in their lives in this country. The organization also mentions that being obese will increase the risk of advanced prostate cancer. Thus, the prevalence of prostate cancer induced by obesity is set to rise in the UK., which would bolster the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
High Accuracy Feature to Fuel Demand for Ultrasound Urology Imaging Solutions
In terms of product type, the ultrasound systems segment is estimated to account for approximately 54.6% of the urology imaging systems market share in 2022, predicts FMI. The high reliability and accuracy provided by ultrasound systems in terms of diagnosis is anticipated to propel their demand in the assessment period.
The fluoroscopy-based systems will remain the second-leading segment, contributing around 45.4% of the market share till 2022, finds FMI. Unlike standard radiographs, fluoroscopy-based systems deliver images in an inverted grayscale. The ongoing evolution in the field of urology imaging solutions is projected to aid the development of advanced fluoroscopy-based systems with 3-D capabilities. This is likely to spur the segment’s growth.
Hospitals are Preferring Narrow Band Imaging Cystoscopy Technology
Based on end user, the hospitals segment is anticipated to remain at the forefront in terms of the urology imaging systems market share. The surging demand for minimally invasive techniques owing to the need to shorten the length of hospital stay, reduce the infection rate, and lower the blood loss across the globe is likely to increase people’s preference for hospitals.
The increasing number of hospitals offering state-of-the-art medical services, such as narrow band imaging cystoscopy technology in both developed and emerging economies is expected to push the segment forward. Many renowned companies are tying up with hospitals worldwide to install their in-house solutions for providing better treatment options to patients. This will also emerge as a chief growth driver.
Some of the key players operating in the urology imaging systems market are focusing on the production of novel systems to cater to the high demand from patients across the globe. Other players are conducting extensive research and development activities to introduce technologically developed urology imaging solutions. A few of them are also participating in the acquisition strategy to expand their existing product portfolios and gain a competitive edge in the market.
For instance,
In January 2022, Olympus, a manufacturer of optics and reprography products headquartered in Japan, published the findings of independent clinical studies in the Journal of Urology. The study found that the treatment of kidney stones with SOLTIVE Premium SuperPulsed Laser System can provide the potential for lower procedures costs, better patient outcomes, and shorter procedure times, as compared to those performed with Holmium: YAG.
In January 2022, Promaxo, Inc., a medical imaging, robotics, and AI technology company based in California, sold its in-office MRI system to Kasraeian Urology. The USA. FDA recently approved the company’s single-sided MRI system equipped with AI-based imaging for in-office use. It would enable hospitals and practices to seamlessly and accurately guide prostate interventions, thereby overcoming the limitations of conventional MRI systems.
| Attribute | Details |
|---|---|
| Forecast Period | 2013 to 2021 |
| Historical Data Available for | 2022 to 2028 |
| Market Analysis | Units for Volume and USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; India; and the Middle East & Africa. |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others. |
| Key Market Segments Covered | Product Type, End Use, and Region |
| Key Companies Profiled | Philips Healthcare; GE Healthcare; Siemens Healthcare; Analogic Corporation; Esaote S.p.A.; Samsung Medison Co. Ltd.; FUJIFILM Holdings Corporation; Hitachi Medical Corporation; Toshiba Corporation; Mindray Medical International Limited |
| Pricing | Available upon Request |
The global urology imaging systems market is expected to reach a valuation of USD 391.6 Million in 2022.
The global urology imaging systems market grew at a healthy 3.8% CAGR between 2013 and 2021.
The increasing prevalence of prostate cancer and the rising demand for minimally invasive techniques are the key trends boosting the sales of urology imaging systems.
Philips Healthcare, GE Healthcare, Siemens Healthcare, Analogic Corporation, Esaote S.p.A., Samsung Medison Co. Ltd., FUJIFILM Holdings Corporation, and Hitachi Medical Corporation are some of the leading players present in the global urology imaging systems market.
The ultrasound systems segment is anticipated to account for 54.6% of the urology imaging systems market share in 2022.
The fluoroscopy-based systems segment is projected to account for 45.4% of the urology imaging systems market share in the forecast period.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Key Success Factors 5. Global Market Comparative Analysis 6. Global Market Demand (in Value or Size in USD Million) Analysis 2013 to 2021 and Forecast, 2022 to 2028 7. Market Background 8. Global Market Analysis 2013 to 2021 and Forecast 2022 to 2028, by Product Type 8.1. Ultrasound Systems 8.2. Fluoroscopy Based Systems (Conventional radiology) 9. Global Market Analysis 2013 to 2021 and Forecast 2022 to 2028, by End User 9.1. Hospitals 9.2. Ambulatory Surgical Centers 9.3. Diagnosis Centers 9.4. Clinics 10. Global Market Analysis 2013 to 2021 and Forecast 2022 to 2028, by Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. East Asia 10.5. South Asia 10.6. Oceania 10.7. Middle East and Africa (MEA) 11. North America Market Analysis 2013 to 2021 and Forecast 2022 to 2028 12. Latin America Market Analysis 2013 to 2021 and Forecast 2022 to 2028 13. Europe Market Analysis 2013 to 2021 and Forecast 2022 to 2028 14. South Asia Market Analysis 2013 to 2021 and Forecast 2022 to 2028 15. East Asia Market Analysis 2013 to 2021 and Forecast 2022 to 2028 16. Oceania Market Analysis 2013 to 2021 and Forecast 2022 to 2028 17. Middle East and Africa Market Analysis 2013 to 2021 and Forecast 2022 to 2028 18. Emerging Countries Market Analysis 2013 to 2021 and Forecast 2022 to 2028 19. Market Structure Analysis 20. Competition Analysis 20.1. Philips Healthcare 20.2. GE Healthcare 20.3. Siemens Healthcare 20.4. Analogic Corporation 20.5. Esaote S.p.A. 20.6. Samsung Medison Co. Ltd. 20.7. FUJIFILM Holdings Corporation 20.8. Mindray Medical International Limited 20.9. Toshiba Corporation 20.10. Hitachi Medical Corporation 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Urology Imaging Systems Market
